Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
PORTLAND, IL, UNITED STATES, February 6, 2025 /EINPresswire / -- Alarming rise in prevalence of disorders such as cancer and diabetes, rise in healthcare expenditures, rise in government & private ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...
MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...
Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...
Learn more about whether ICU Medical, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...
Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $5.00.
UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
Learn more about whether Enovis Corporation or ICU Medical, Inc. is a better investment based on AAII's A+ Investor grades, ...
Systems (NASDAQ: KRMD), a medical technology firm with a market capitalization of $194 million, announced a partnership with a global pharmaceutical manufacturer to conduct a Phase III clinical trial.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果